Suppr超能文献

相似文献

1
Triple-negative breast cancer: the reality in Chile and in Latin America.
Ecancermedicalscience. 2019 Jan 22;13:893. doi: 10.3332/ecancer.2019.893. eCollection 2019.
2
Breast cancer in young women in Latin America: an unmet, growing burden.
Oncologist. 2013;18 Suppl:26-34. doi: 10.1634/theoncologist.18-S2-26.
4
Founder and Recurrent Mutations in BRCA1 and BRCA2 Genes in Latin American Countries: State of the Art and Literature Review.
Oncologist. 2016 Jul;21(7):832-9. doi: 10.1634/theoncologist.2015-0416. Epub 2016 Jun 10.
5
Trends in cervical cancer mortality in the Americas.
Bull Pan Am Health Organ. 1996 Dec;30(4):290-301.
6
The invisible force. Midlife and older women.
Links. 1993 Winter;9(5):22-3, 29.
7
Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
Clin Breast Cancer. 2018 Oct;18(5):e1229-e1235. doi: 10.1016/j.clbc.2017.12.014. Epub 2017 Dec 30.
8
Real-world data on triple-negative breast cancer in Latin America and the Caribbean.
Ecancermedicalscience. 2023 Nov 21;17:1635. doi: 10.3332/ecancer.2023.1635. eCollection 2023.
9
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Breast Cancer Res Treat. 2018 Jul;170(1):101-109. doi: 10.1007/s10549-018-4727-9. Epub 2018 Feb 22.
10
The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
Breast Cancer Res Treat. 2015 Apr;150(2):389-94. doi: 10.1007/s10549-015-3312-8. Epub 2015 Feb 26.

引用本文的文献

1
Clinical and radiological manifestations associated with triple-negative breast cancer in women from northern Peru. A case-control study.
Ecancermedicalscience. 2024 Jun 27;18:1720. doi: 10.3332/ecancer.2024.1720. eCollection 2024.
2
Therapeutic pattern and progress of neoadjuvant treatment for triple-negative breast cancer.
Oncol Lett. 2022 May 19;24(1):219. doi: 10.3892/ol.2022.13340. eCollection 2022 Jul.
4
Clinicopathologic and Genomic Features in Triple-Negative Breast Cancer Between Special and No-Special Morphologic Pattern.
Front Oncol. 2022 Mar 25;12:830124. doi: 10.3389/fonc.2022.830124. eCollection 2022.
7
Engineered IL-7 Receptor Enhances the Therapeutic Effect of AXL-CAR-T Cells on Triple-Negative Breast Cancer.
Biomed Res Int. 2020 Jan 2;2020:4795171. doi: 10.1155/2020/4795171. eCollection 2020.

本文引用的文献

1
Environmental Determinants of Breast Cancer.
Annu Rev Public Health. 2018 Apr 1;39:113-133. doi: 10.1146/annurev-publhealth-040617-014101. Epub 2018 Jan 12.
2
Breast cancer statistics, 2017, racial disparity in mortality by state.
CA Cancer J Clin. 2017 Nov;67(6):439-448. doi: 10.3322/caac.21412. Epub 2017 Oct 3.
3
Cancer mortality predictions for 2017 in Latin America.
Ann Oncol. 2017 Sep 1;28(9):2286-2297. doi: 10.1093/annonc/mdx301.
6
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4.
7
Molecular alterations in triple-negative breast cancer-the road to new treatment strategies.
Lancet. 2017 Jun 17;389(10087):2430-2442. doi: 10.1016/S0140-6736(16)32454-0. Epub 2016 Dec 7.
9
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
PLoS One. 2016 Jun 16;11(6):e0157368. doi: 10.1371/journal.pone.0157368. eCollection 2016.
10
Socioeconomic inequalities in breast cancer incidence and mortality in Europe-a systematic review and meta-analysis.
Eur J Public Health. 2016 Oct;26(5):804-813. doi: 10.1093/eurpub/ckw070. Epub 2016 May 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验